Synexa Life Sciences
Katie Edwards currently serves as the Head of Study Delivery (UK) at Synexa Life Sciences, a position held since March 2021, following roles as a Scientist and Research Associate within the same company. Prior to this, Katie worked as a Quality Control Associate at Autolus Ltd. from August 2020 to March 2021 and has previous experience as a Laboratory Technician at The Binding Site from February 2018 to September 2019. Additionally, Katie has held various roles in the food and beverage sector at Mytime Active and Bellini's. Academically, Katie earned a Master of Science in Immunology and Immunotherapy from the University of Birmingham and a Bachelor of Science in Biology from Cardiff University.
This person is not in any offices
Synexa Life Sciences
Synexa Life Sciences is a global provider of biomarker and bioanalytical services, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of 150 across five global laboratory locations; Cape Town, London, Berlin, Turku (Finland) and Rockville (Maryland USA), we provide innovative solutions to support our customers to achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, clinical bioanalysis, soluble biomarker analysis (utilising MSD, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genomic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and our ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. We partner with our customers to contribute to the furtherment of scientific development and ultimately better management and treatment of human health. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.